Insights

Global Expansion Vaxxinova operates in more than 75 countries with facilities across Europe, Asia, Americas, and Africa, indicating a broad international footprint that can present opportunities for deploying new vaccines and diagnostic solutions tailored to regional animal health challenges.

Innovative R&D Focus Strong investment in research and development, demonstrated by recent vaccine advancements and acquisition activities such as Newportlabs, positions Vaxxinova as a key player capable of introducing innovative products to meet evolving market needs, fostering potential sales for cutting-edge animal health vaccines.

Recent Leadership Growth The addition of senior executives like the COO and Chief Scientific Officer reflects expansion in operational capability and scientific expertise, indicating readiness to scale up product offerings and penetrate new market segments, creating opportunities for strategic partnerships and sales channels.

Product Development & Launches Recent product launches, such as the Vaxxon SRP SE vaccine, and involvement in disease control conferences showcase Vaxxinova’s active role in addressing pressing animal health issues, opening doors for collaborative sales prospects with veterinary clinics, farms, and government agencies seeking new disease management solutions.

Market Position & Client Potential Operating within the competitive landscape alongside companies like Zoetis and Elanco, Vaxxinova’s focus on specialized vaccines and diagnostic solutions for livestock and fish offers targeted sales opportunities with large farming operations, aquaculture businesses, and veterinary service providers looking to enhance disease prevention strategies.

Vaxxinova Tech Stack

Vaxxinova uses 8 technology products and services including WordPress, MySQL, oEmbed, and more. Explore Vaxxinova's tech stack below.

  • WordPress
    Content Management System
  • MySQL
    Database
  • oEmbed
    Dev Tools
  • Font Awesome
    Font Scripts
  • Claro
    Human Resource Management System
  • PHP
    Programming Languages
  • HSTS
    Security
  • Google Tag Manager
    Tag Management

Media & News

Vaxxinova's Email Address Formats

Vaxxinova uses at least 1 format(s):
Vaxxinova Email FormatsExamplePercentage
First.Last@vaxxinova.comJohn.Doe@vaxxinova.com
89%
First.MiddleLast@vaxxinova.comJohn.MichaelDoe@vaxxinova.com
5%
FirstMiddleLast@vaxxinova.comJohnMichaelDoe@vaxxinova.com
4%
Last.First@vaxxinova.comDoe.John@vaxxinova.com
2%

Frequently Asked Questions

What is Vaxxinova's official website and social media links?

Minus sign iconPlus sign icon
Vaxxinova's official website is vaxxinova.com and has social profiles on LinkedIn.

What is Vaxxinova's SIC code NAICS code?

Minus sign iconPlus sign icon
Vaxxinova's SIC code is 2834 - Pharmaceutical Preparations NAICS code is 54194 - Veterinary Services.

How many employees does Vaxxinova have currently?

Minus sign iconPlus sign icon
As of December 2025, Vaxxinova has approximately 1K employees across 5 continents, including EuropeSouth AmericaAsia. Key team members include Chief Operating Officer: O. R.Chief Scientific Officer: K. M.Head Of Quality Control: F. F.. Explore Vaxxinova's employee directory with LeadIQ.

What industry does Vaxxinova belong to?

Minus sign iconPlus sign icon
Vaxxinova operates in the Veterinary Services industry.

What technology does Vaxxinova use?

Minus sign iconPlus sign icon
Vaxxinova's tech stack includes WordPressMySQLoEmbedFont AwesomeClaroPHPHSTSGoogle Tag Manager.

What is Vaxxinova's email format?

Minus sign iconPlus sign icon
Vaxxinova's email format typically follows the pattern of First.Last@vaxxinova.com. Find more Vaxxinova email formats with LeadIQ.

When was Vaxxinova founded?

Minus sign iconPlus sign icon
Vaxxinova was founded in 2010.

Vaxxinova

Veterinary ServicesGelderland, Netherlands1001-5000 Employees

Vaxxinova develops, produces and markets a wide range of innovative vaccines and diagnostic services to protect livestock and fish against diseases. We create high quality solutions to improve animal health and to support our customers. We believe that innovation and excellence in research are essential to produce premium products that match the current and future requirements in animal health. That is why Vaxxinova invests strongly in R&D. 

Locations
Our current network comprises production, research & development, sales and diagnostic facilities in 12 countries: Brazil, Chile, Croatia, Germany, Italy, Japan, Jordan, Norway, the Netherlands, South Africa, Thailand and the USA. Vaxxinova is active in more than 75 countries.

Job opportunities
We are currently expanding our organization, both locally and at the head office. We are looking for new talents and professionals who feel at home in a driven, entrepreneurial and down to earth working environment. Vaxxinova offers their employees excellent opportunities for further professional development.

Background
Vaxxinova is part of the family-owned EW Group, a German based company specialized in the field of Life Sciences: genetics, nutrition and animal health. The EW Group is highly committed to R&D, operates in more than 165 countries and records consistent international growth.

Section iconCompany Overview

SIC Code
2834 - Pharmaceutical Preparations
NAICS Code
54194 - Veterinary Services
Founded
2010
Employees
1001-5000

Section iconFunding & Financials

  • $1M

    Vaxxinova's revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $1M

    Vaxxinova's revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.